Suazette R. Mooring, Ph.D. - Publications

2010 Georgia State University, Atlanta, GA, United States 
Organic Chemistry, Pharmaceutical Chemistry

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gaines T, Garcia F, Virani S, Liang Z, Yoon Y, Oum YH, Shim H, Mooring SR. Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors. European Journal of Medicinal Chemistry. 181: 111562. PMID 31377592 DOI: 10.1016/j.ejmech.2019.111562  0.4
2018 Virani S, Liang Z, Yoon Y, Shim H, Mooring SR. Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists. Bioorganic & Medicinal Chemistry Letters. PMID 30514601 DOI: 10.1016/j.bmcl.2018.11.052  0.4
2016 Gaines T, Camp D, Bai R, Liang Z, Yoon Y, Shim H, Mooring SR. Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors. Bioorganic & Medicinal Chemistry. PMID 27576294 DOI: 10.1016/j.bmc.2016.08.018  1
2016 Bai R, Liang Z, Yoon Y, Liu S, Gaines T, Oum Y, Shi Q, Mooring SR, Shim H. Symmetrical bis-tertiary amines as novel CXCR4 inhibitors. European Journal of Medicinal Chemistry. 118: 340-350. PMID 27179215 DOI: 10.1016/j.ejmech.2016.04.040  1
2015 Mooring RD, Mooring SR. Predictors of Timely Baccalaureate Attainment for Underrepresented Minority Community College Transfer Students Community College Journal of Research and Practice. 1-14. DOI: 10.1080/10668926.2015.1070775  1
2015 Burrows NL, Mooring SR. Using concept mapping to uncover students' knowledge structures of chemical bonding concepts Chemistry Education Research and Practice. 16: 53-66. DOI: 10.1039/c4rp00180j  1
2014 Mooring SR, Gaines T, Liang Z, Shim H. Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4. Heterocyclic Communications. 20: 149-153. PMID 25620839 DOI: 10.1515/hc-2014-0041  1
2013 Mooring SR, Liu J, Liang Z, Ahn J, Hong S, Yoon Y, Snyder JP, Shim H. Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitors. Chemmedchem. 8: 622-32. PMID 23468189 DOI: 10.1002/cmdc.201200582  1
2012 Shi Q, Yin S, Kaluz S, Ni N, Devi NS, Mun J, Wang D, Damera K, Chen W, Burroughs S, Mooring SR, Goodman MM, Van Meir EG, Wang B, Snyder JP. Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor. Acs Medicinal Chemistry Letters. 3: 620-5. PMID 24936238 DOI: 10.1021/ml300042k  1
2011 Mooring SR, Jin H, Devi NS, Jabbar AA, Kaluz S, Liu Y, Van Meir EG, Wang B. Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway. Journal of Medicinal Chemistry. 54: 8471-89. PMID 22032632 DOI: 10.1021/jm201018g  1
2011 Tan C, de Noronha RG, Devi NS, Jabbar AA, Kaluz S, Liu Y, Mooring SR, Nicolaou KC, Wang B, Van Meir EG. Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 5528-32. PMID 21831638 DOI: 10.1016/j.bmcl.2011.06.099  1
2011 Mooring SR, Wang B. HIF-1 inhibitors as anti-cancer therapy Science China Chemistry. 54: 24-30. DOI: 10.1007/s11426-010-4187-5  1
Show low-probability matches.